Aurora Cannabis Inc
TSX:ACB
Aurora Cannabis Inc
Cash Equivalents
Aurora Cannabis Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurora Cannabis Inc
TSX:ACB
|
Cash Equivalents
CA$144.4m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
73%
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash Equivalents
$733m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
Canopy Growth Corp
TSX:WEED
|
Cash Equivalents
CA$55.1m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Cash Equivalents
$855.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash Equivalents
$118.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Cash Equivalents
$26.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurora Cannabis Inc's Cash Equivalents?
Cash Equivalents
144.4m
CAD
Based on the financial report for Dec 31, 2023, Aurora Cannabis Inc's Cash Equivalents amounts to 144.4m CAD.
What is Aurora Cannabis Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
73%
Over the last year, the Cash Equivalents growth was -44%. The average annual Cash Equivalents growth rates for Aurora Cannabis Inc have been -28% over the past three years , 25% over the past five years , and 73% over the past ten years .